| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,747 |
1,535 |
$70K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
953 |
897 |
$52K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
58 |
57 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
111 |
66 |
$4K |
| 99233 |
Prolong inpt eval add15 m |
53 |
28 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
27 |
27 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
186 |
159 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
21 |
21 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
52 |
48 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
19 |
19 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
245 |
243 |
$1K |
| 99442 |
|
12 |
12 |
$695.28 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
40 |
38 |
$395.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25 |
23 |
$342.25 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
13 |
12 |
$239.69 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
65 |
53 |
$100.35 |
| 81003 |
|
53 |
49 |
$99.11 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
40 |
36 |
$48.50 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
103 |
102 |
$0.01 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
150 |
138 |
$0.00 |